{"date":"2025-07-01","count":16,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1271-2025-07-01-1846-13rpxz5","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-07-01","time":"18:46:25","subject":"公告本公司訂定除息基準日等相關事宜","clause":"第31款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-07-01 18:46，「公告本公司訂定除息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-07-01-1827-17nobjp","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-07-01","time":"18:27:38","subject":"本公司研發之異體間質幹細胞新藥HeXell-2020治療老年衰弱症向美國食品藥物管理局(FDA)提出Phase I 人體臨床試驗申請","clause":"第44款","fact_date":"2025-07-01","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-07-01 18:27，「本公司研發之異體間質幹細胞新藥HeXell-2020治療老年衰弱症向美國食品藥物管理局(FDA)提出Phase I 人體」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-07-01-1757-1o7gfsu","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-07-01","time":"17:57:31","subject":"公告本公司向關係人租賃取得不動產使用權資產(補充公告交易相對人異動)","clause":"第20款","fact_date":"2025-07-01","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-07-01 17:57，「公告本公司向關係人租賃取得不動產使用權資產(補充公告交易相對人異動)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-07-01-1727-p3l3cc","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-07-01","time":"17:27:50","subject":"本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-07-01 17:27，「本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-07-01-1715-1w59yfm","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-07-01","time":"17:15:39","subject":"公告訊聯生技與佛教慈濟醫療財團法人台中慈濟醫院合作提出細胞治療技術計畫申請","clause":"第53款","fact_date":"2025-07-01","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-07-01 17:15，「公告訊聯生技與佛教慈濟醫療財團法人台中慈濟醫院合作提出細胞治療技術計畫申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-07-01-1651-1fqkmsr","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-07-01","time":"16:51:31","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-07-01 16:51，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-07-01-1631-49bmw7","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-07-01","time":"16:31:22","subject":"公告本公司114年度股東臨時會通過解除董事競業禁止","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-07-01 16:31，「公告本公司114年度股東臨時會通過解除董事競業禁止」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-07-01-1630-1ja1uui","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-07-01","time":"16:30:33","subject":"公告本公司114年度股東臨時會獨立董事補選當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-07-01 16:30，「公告本公司114年度股東臨時會獨立董事補選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-07-01-1629-ub84r7","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-07-01","time":"16:29:54","subject":"公告本公司114年第一次股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-07-01 16:29，「公告本公司114年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-07-01-1547-84nc9j","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-07-01","time":"15:47:19","subject":"代重要子公司越南普惠醫療工藝責任有限公司公告向關係人取得使用權資產案(更新113/12/9公告之交易單位數量及總金額)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-07-01 15:47，「代重要子公司越南普惠醫療工藝責任有限公司公告向關係人取得使用權資產案(更新113/12/9公告之交易單位數量及總金額)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-07-01-1535-54swv6","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-07-01","time":"15:35:23","subject":"公告本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-07-01 15:35，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-07-01-1532-j8aww1","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-07-01","time":"15:32:37","subject":"公告本公司114年除息基準日","clause":"第31款","fact_date":"2025-07-01","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-07-01 15:32，「公告本公司114年除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-01-1517-1o7gfsu","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-01","time":"15:17:51","subject":"公告本公司向關係人租賃取得不動產使用權資產(補充公告交易相對人異動)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-01 15:17，「公告本公司向關係人租賃取得不動產使用權資產(補充公告交易相對人異動)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-01-1517-1wxj0ll","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-01","time":"15:17:33","subject":"公告本公司董事會通過委任第二屆永續發展委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-01 15:17，「公告本公司董事會通過委任第二屆永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-01-1517-6e3jxd","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-01","time":"15:17:14","subject":"公告本公司董事會通過委任第六屆薪酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-01 15:17，「公告本公司董事會通過委任第六屆薪酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-07-01-0317-1uhpy0h","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-07-01","time":"03:17:36","subject":"公告本公司接獲起訴狀，要求出席參加調解庭","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-07-01 03:17，「公告本公司接獲起訴狀，要求出席參加調解庭」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}